Analgesic Market Synopsis

Analgesic Market Size Was Valued at USD 30340 Million in 2023 and is Projected to Reach USD 53250 Million by 2032, Growing at a CAGR of 6.4% From 2024-2032.

Analgesics are medications that are used in the management and treatment of pain which include several classes of medications such as acetaminophen, antidepressants, nonsteroidal anti-inflammatory drugs, antiepileptics, local anesthetics, and opioids.

• Analgesics like Opioid drugs are useful in the treatment of general postoperative pain, severe pain, and other conditions. The use of opioids to relieve the pain associated with kidney stones or gallstones presumably depends on their ability to affect opioid receptors in these tissues and inhibit contractility.
• They are also able to relieve abdominal distress and fluid loss of diarrhea. Central receptors appear to account for the ability of morphine and analogs to suppress coughing.
• Antiseptics are used in medical practice to prevent or combat bacterial infections of superficial tissues and to sterilize instruments and infected material.
• Anti-inflammatory analgesics are used to relieve mild to moderate pain through actions that reduce inflammation. Non-prescription analgesics are most commonly used for the treatment of common headaches.
• Aspirin is known as a salicylate which works by blocking a certain natural substance in your body to reduce pain and swelling.

Top Active Players Involved are:

“Reckitt Benckiser Group PLC (UK), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Sanofi S.A. (France), AstraZeneca plc (UK), Bristol-Myers Squibb Company (USA), Johnson & Johnson (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (USA), Merck & Co., Inc. (USA), Bayer AG (Germany), Abbott Laboratories (USA), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (USA), Endo International plc (Ireland), Perrigo Company plc (Ireland), Mylan N.V. (USA), Mallinckrodt plc (Ireland), Cardinal Health, Inc. (USA), McKesson Corporation (USA), Amgen Inc. (USA), Celgene Corporation (USA), Dr. Reddy's Laboratories Ltd. (India), Assertio Therapeutics, Inc. (USA), Alkem Laboratories Limited (India)and Other Active Players.”

Analgesic Market Trend Analysis

Higher Incidences of Chronic Pain

• The increasing occurrence of pain has led to an increased use of drugs that effectively manage pain. People with long-lasting pain look for ways to alleviate it and use painkillers to enhance their quality of life.
• As the population is increasing the chances of developing chronic pain are also rising. Elderly individuals are at a higher risk for developing arthritis and degenerative joint diseases, which results in an increased need for pain relievers.
• Chronic pain is frequently developed into different medical issues such as cancer, multiple sclerosis, and diabetes. As these diseases become more common, the demand for pain relievers to treat the pain is also increasing.
• Improvements in medical expertise and diagnostic tools have resulted in enhanced recognition and identification of chronic pain disorders. As awareness grows, more people are looking for the right treatment options like pain relievers. Inactive habits, obesity, bad posture, and more sports injuries are also leading to the rise of chronic pain cases.
• Chronic pain is also rising in the research and advancement in the area of pain relief medications. Pharmaceutical firms are dedicating resources to creating new pain-relief products with fewer side effects, aiming to improve pain management. Hence, in this way, Chronic Pain is acting as a driver in the Analgesics Market.

Opportunity

Increasing Initiatives From Government and Private Organizations

• Government and private organizations are launching awareness campaigns to educate the public about pain management solutions and the availability of analgesics. These campaigns help to create a larger consumer base for analgesics by increasing awareness about their benefits and encouraging individuals to seek appropriate treatment.
• The funding from the government and private investments in the research and development of analgesics also fosters innovation and leads to the development of more effective and targeted pain management.
• Supportive regulations that streamline the approval process for analgesics can encourage pharmaceutical companies to invest in the development of new products, ensuring a steady supply of innovative analgesics in the market.
• Increased focus on healthcare infrastructure by both government and private organizations can improve patient access to pain management services, including analgesics. This can include the establishment of specialized pain clinics, increased availability of healthcare professionals specialized in pain management, and the integration of pain management into healthcare systems.
• They often collaborate with academic institutions, hospitals, and pharmaceutical companies to foster research and development in the field of pain management. To encourage the usage of analgesics they may also offer incentives, subsidies, or reimbursement programs, particularly for patients who have limited financial resources. Hence, in this way Increasing Initiatives from Government and Private Organizations can be an opportunity in Analgesics Market.

Analgesic Market Segment Analysis:

The analgesic Market Segmented on the basis of Drug Class, Type, Application, Route of Administration, and Distribution Channel.

By Drug Class, Non-Opioids Segment Is Expected to Dominate the Market During the Forecast Period

• Non-opioid analgesics are commonly used to treat mild and moderate acute and chronic pain. They can be used as monotherapy; however, they have greater efficacy in combination with weak and strong opioids. Unlike opioids, long-term use of non-steroidal anti-inflammatory drugs does not lead to physical dependence.
• Acetaminophen analgesics are used to reduce the fever, Aspirin and other NSAIDs also help to alleviate the pain and reduce fever and inflammation by decreasing the synthesis and release of prostaglandins, which are pro-inflammatory molecules.
• Topical non-opioid medications like lidocaine and capsaicin are applied to the skin locally. Lidocaine works by blocking nerve signals to the brain from the site of injury. It causes a temporary loss of feeling in the area to which it is applied.
• They also play an important role in the emergency department and intensive care unit. For example, a double-blind clinical trial found that for emergency department patients with acute extremity pain, combinations of non-opioid analgesics may be as effective in reducing pain as opioids. Hence, in this way, Non-Opioids Segment is expected to dominate in Analgesics Market.

By Route of Administration, Oral Segment Held the Largest Share In 2023

• Oral analgesics have many pain conditions such as headaches, muscle aches, dental pain, menstrual pain, and other minor injuries. It is a convenient and widely used form of pain relief following a cesarean section.
• They also help relieve Acute dental pain, which can affect the mouth's hard and soft tissues. They are used to manage acute dental pain, by using various oral analgesics.
• They are used to treat acute pain in adults with at least moderate pain following surgery, who have been given a single dose of oral analgesic taken alone.
• For acute or short-term pain, such as a twisted ankle or headache, aches, and pains like menstrual cramps or muscle soreness. They are also used to treat the ulcers in the mouth.
• Oral analgesics are generally available in tablet or capsule form, making them easy to consume hence they offer convenience to patients, as they can be self-administered without the need for healthcare professional assistance.
• Many oral analgesics have a relatively fast onset of action, providing quick relief for acute or short-term pain. Hence, in this way, Oral Analgesics acts as a dominant segment in the Analgesics Market.

Analgesic Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

• The increased occurrence of chronic pain has led to a greater need for pain relief medications that are successful. People experiencing long-term pain look for solutions and rely on pain relievers to enhance their quality of life. The increasing population in the Asia Pacific region is closely linked to a rise in pain-related issues such as chronic pain and musculoskeletal disorders, leading to a greater need for analgesics in this area.
• The increased occurrence of chronic pain has led to a greater need for pain relief medications that are successful. People experiencing long-term pain look for solutions and rely on pain relievers to enhance their quality of life.
• Elderly individuals often suffer from long-lasting pain caused by age-related issues like osteoarthritis and neuropathies. The high demand for pain relievers within this particular group has led to their control of the market in the area.
• The Progress in producing pharmaceuticals and improvements in pain relief treatments have had a beneficial effect on the analgesics market in this region. The introduction of new formulations, extended-release drugs, and specialized drug delivery systems has increased treatment choices and driven market expansion.
• Government efforts to improve pain management, raise awareness about pain relievers, and make them more affordable have strengthened their control over the market. There are several top pharmaceutical manufacturers in this region. These companies dominate the pain relief market and consistently allocate resources to Research and Development which is making this region dominating in the Analgesics Market.

Analgesic Market Active Players

• Reckitt Benckiser Group Plc (UK)
• Glaxosmithkline Plc (UK)
• Novartis Ag (Switzerland)
• Sanofi S.A. (France)
• Astrazeneca Plc (UK)
• Bristol-Myers Squibb Company (USA)
• Johnson & Johnson (USA)
• Hoffmann-La Roche Ltd. (Switzerland)
• Pfizer Inc. (USA)
• Merck & Co., Inc. (USA)
• Bayer Ag (Germany)
• Abbott Laboratories (USA)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Eli Lilly And Company (USA)
• Endo International Plc (Ireland)
• Perrigo Company Plc (Ireland)
• Mylan N.V. (USA)
• Mallinckrodt Plc (Ireland)
• Cardinal Health, Inc. (USA)
• Mckesson Corporation (USA)
• Amgen Inc. (USA)
• Celgene Corporation (USA)
• Reddy's Laboratories Ltd. (India)
• Assertio Therapeutics, Inc. (USA)
• Alkem Laboratories Limited (India) and Other Active Players.

Key Industry Developments in the Analgesic Market:

• In Feb 2024, Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, Launched COMBOGESIC® IV (acetaminophen and ibuprofen) injection in the US. It is used for adults by intravenous route of administration to get relief from mild to moderate pain.
• In Aug 2023, Kenvue Inc. the world’s largest pure-play consumer health company by revenue, launched a new topical Tylenol® Precise™ Pain Relieving Cream hat provides dosing that supports up to 8 hours.